Light Mode
$8.24 ↑ +0.00 (+0.00%) Trading Up from the previous close of $8.24, $0.73 below the day’s high of $8.97
+2.77 (+50.64%) / 6M
Momentum, market sentiment, and recent alerts
AKTX reads poor: price sits below both the 20- and 200-day averages, the 12-month move is +1036.6%.
No alerts for AKTX in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Akari Therapeutics Plc is a clinical-stage biopharmaceutical company. It engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. The company was founded on October 7, 2004 and is headquartered in Tampa, FL.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.